At the time of writing, Unitedhealth Group Inc [UNH] stock is trading at $498.24, up 0.73%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The UNH shares have gain 2.84% over the last week, with a monthly amount glided 0.58%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Unitedhealth Group Inc [NYSE: UNH] stock has seen the most recent analyst activity on June 05, 2024, when HSBC Securities upgraded its rating to a Buy but kept the price target unchanged to $580 for it. Previously, Robert W. Baird started tracking the stock with Outperform rating on May 30, 2024, and set its price target to $597. On April 04, 2024, upgrade upgraded it’s rating to Hold but maintained its price target of $460 on the stock. Barclays started tracking the stock assigning a Overweight rating and suggested a price target of $551 on March 06, 2024. HSBC Securities downgraded its rating to a Reduce and reduced its price target to $480 on December 18, 2023. UBS upgraded its rating to Buy for this stock on October 16, 2023, and upped its price target to $640. In a note dated September 06, 2023, HSBC Securities initiated an Hold rating and provided a target price of $540 on this stock.
For the past year, the stock price of Unitedhealth Group Inc fluctuated between $436.38 and $554.70. Currently, Wall Street analysts expect the stock to reach $558.93 within the next 12 months. Unitedhealth Group Inc [NYSE: UNH] shares were valued at $498.24 at the most recent close of the market. An investor can expect a potential return of 12.18% based on the average UNH price forecast.
Analyzing the UNH fundamentals
According to Unitedhealth Group Inc [NYSE:UNH], the company’s sales were 379.49B for trailing twelve months, which represents an 8.56% jump. Gross Profit Margin for this corporation currently stands at 0.24% with Operating Profit Margin at 0.09%, Pretax Profit Margin comes in at 0.06%, and Net Profit Margin reading is 0.04%. To continue investigating profitability, this company’s Return on Assets is posted at 0.05, Equity is 0.17 and Total Capital is 0.18. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.85.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 494.93 points at the first support level, and at 491.62 for the second support level. However, for the 1st resistance point, the stock is sitting at 500.01, and for the 2nd resistance point, it is at 501.78.
Ratios To Look Out For
It is important to note that Unitedhealth Group Inc [NYSE:UNH] has a current ratio of 0.85. Considering the valuation of this stock, the price to sales ratio is 1.21, the price to book ratio is 5.29 and price to earnings (TTM) ratio is 30.44.
Transactions by insiders
Recent insider trading involved McSweeney Erin, EVP & Chief People Officer, that happened on Mar 08 ’24 when 1236.0 shares were sold. Chief Accounting Officer, ROOS THOMAS E completed a deal on Feb 23 ’24 to sell 858.0 shares. Meanwhile, CEO, UnitedHealthcare THOMPSON BRIAN R sold 28943.0 shares on Feb 16 ’24.
